Your browser doesn't support javascript.
loading
CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer.
Xiang, Jingyu; Hurchla, Michelle A; Fontana, Francesca; Su, Xinming; Amend, Sarah R; Esser, Alison K; Douglas, Garry J; Mudalagiriyappa, Chidananda; Luker, Kathryn E; Pluard, Timothy; Ademuyiwa, Foluso O; Romagnoli, Barbara; Tuffin, Gérald; Chevalier, Eric; Luker, Gary D; Bauer, Michael; Zimmermann, Johann; Aft, Rebecca L; Dembowsky, Klaus; Weilbaecher, Katherine N.
Afiliación
  • Xiang J; Division of Molecular Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Hurchla MA; Division of Molecular Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Fontana F; Division of Molecular Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri. Division of Bone and Mineral Diseases, Musculoskeletal Research Center, Washington University School of Medicine, St. Louis, Missouri.
  • Su X; Division of Molecular Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Amend SR; Division of Molecular Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Esser AK; Division of Molecular Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Douglas GJ; Polyphor Ltd., Allschwil, Switzerland.
  • Mudalagiriyappa C; Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
  • Luker KE; Department of Radiology, Center for Molecular Imaging, University of Michigan Medical School, Ann Arbor, Michigan. Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan. Department of Biomedical Engineering, University of Michigan Medical School, Ann A
  • Pluard T; Saint Luke's Cancer Institute, Kansas City, Missouri.
  • Ademuyiwa FO; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.
  • Romagnoli B; Polyphor Ltd., Allschwil, Switzerland.
  • Tuffin G; Polyphor Ltd., Allschwil, Switzerland.
  • Chevalier E; Polyphor Ltd., Allschwil, Switzerland.
  • Luker GD; Department of Radiology, Center for Molecular Imaging, University of Michigan Medical School, Ann Arbor, Michigan. Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan. Department of Biomedical Engineering, University of Michigan Medical School, Ann A
  • Bauer M; Polyphor Ltd., Allschwil, Switzerland.
  • Zimmermann J; Polyphor Ltd., Allschwil, Switzerland.
  • Aft RL; Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
  • Dembowsky K; Polyphor Ltd., Allschwil, Switzerland.
  • Weilbaecher KN; Division of Molecular Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri. kweilbae@dom.wustl.edu.
Mol Cancer Ther ; 14(11): 2473-85, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26269605

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores CXCR4 / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores CXCR4 / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos